These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19253137)

  • 1. Is imatinib mesylate a promising drug in scleroderma due to extensive chronic graft-versus-host disease?
    Papadakis V; Karakasis D; Sfikakis PP; Baltadakis I; Apostolidis J; Evangelou K; Gorgoulis VG; Harhalakis N
    Leuk Lymphoma; 2009 Mar; 50(3):471-4. PubMed ID: 19253137
    [No Abstract]   [Full Text] [Related]  

  • 2. Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.
    de Masson A; Bouaziz JD; Peffault de Latour R; Wittnebel S; Ribaud P; Rubio MT; Micol JB; Suarez F; Nguyen S; Dalle JH; Yakouben K; Robin M; Xhaard A; Adès L; Bourhis JH; Rybojad M; Bagot M; Socié G
    Blood; 2012 Dec; 120(25):5089-90. PubMed ID: 23243159
    [No Abstract]   [Full Text] [Related]  

  • 3. Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease.
    Stadler M; Ahlborn R; Kamal H; Diedrich H; Buchholz S; Eder M; Ganser A
    Blood; 2009 Oct; 114(17):3718-9; author reply 3719-20. PubMed ID: 19850751
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful long-term use of imatinib mesylate in pediatric patients with sclerodermatous chronic GVHD.
    Kim H; Kim NH; Kang HJ; Lee JW; Kim MS; Park KD; Shin HY; Ahn HS
    Pediatr Transplant; 2012 Dec; 16(8):910-2. PubMed ID: 23050745
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy.
    Lazar J; Poonawalla T; Teng JM
    Pediatr Dermatol; 2011; 28(2):172-5. PubMed ID: 21504445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease.
    Fedele R; Martino M; Dattola A; Cuzzola M; Messina G; Irrera G; Iacopino P
    Leuk Lymphoma; 2011 Oct; 52(10):2010-1. PubMed ID: 21663506
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.
    Magro L; Catteau B; Coiteux V; Bruno B; Jouet JP; Yakoub-Agha I
    Bone Marrow Transplant; 2008 Dec; 42(11):757-60. PubMed ID: 18762765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Distler A; Palumbo-Zerr K; Tomcik M; Vollath S; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Am J Pathol; 2012 Nov; 181(5):1672-80. PubMed ID: 22940072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?
    Chunduri S; Dobogai LC; Bruno A; Kadkol S; Rondelli D
    Leukemia; 2005 Mar; 19(3):456-7; author reply 457. PubMed ID: 15674413
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease.
    Magro L; Mohty M; Catteau B; Coiteux V; Chevallier P; Terriou L; Jouet JP; Yakoub-Agha I
    Blood; 2009 Jul; 114(3):719-22. PubMed ID: 19289852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSc in 2011: From mechanisms to medicines.
    Mouthon L
    Nat Rev Rheumatol; 2012 Jan; 8(2):72-4. PubMed ID: 22231235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate.
    Johnson NA; Fetni R; Caplan SN
    Leuk Lymphoma; 2005 Apr; 46(4):629-30. PubMed ID: 16019496
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Zhang FH; Ling YW; Zhai X; Zhang Y; Huang F; Fan ZP; Zhou HS; Jiang QL; Sun J; Liu QF
    Hematology; 2013 May; 18(3):151-7. PubMed ID: 23394269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential clinical application of imatinib mesylate in patients with leukemic large granular lymphocytes.
    Yang J; Loughran TP
    Leuk Lymphoma; 2011 Oct; 52(10):1834-5. PubMed ID: 21699458
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new therapeutic avenue for severe systemic sclerosis: imatinib mesylate].
    Taïeb A; Constans J; Mahon FX
    Rev Med Interne; 2008 Mar; 29(3):173-5. PubMed ID: 17597261
    [No Abstract]   [Full Text] [Related]  

  • 16. Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
    Luo Y; Zhao Y; Tan Y; Shi J; Han X; Zheng Y; Li L; He J; Xie W; Ye X; Cai Z; Lin M; Huang H
    Leuk Res; 2011 Oct; 35(10):1307-11. PubMed ID: 21354617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allo-geneic hematopoietic stem cell transplantation in treatment with T315I mutation of chronic myelogenous leukemia].
    Wang L; Liu H; Zheng C; Tang B; Zhu X; Yao W; Zhang L; Sun Z
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3150-3. PubMed ID: 25573310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
    Cohen MH; Johnson JR; Pazdur R
    Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Graft vs. tumor effect in chronic granulocytic leukemia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 2002; 54(2):154-60. PubMed ID: 12053814
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.